How often are fluid therapy treatments chosen of changed appropriately according to a patient's acid base results in the veterinary patient?

Purpose: The purpose of this study is to assess how frequently intravenous fluidtherapy is chosen in veterinary clinical practice based on the evaluation of acid-baseresults. Material-Method: The study employed a randomized retrospective quantitative design. A total of 20 emergency cases were randomly selected and clinical records were reviewed to determine the choice of intravenous fluid administered based on the patient's venous acid-base status. Results: The results of the study showed that 100% of patients participating were initially treated with intravenous fluid therapy using Hartmann’s solution, with all patients undergoing initial acid-base and electrolyte status analysis. Of these, 45% exhibited normal pH and electrolyte levels, 20% presented with metabolic acidosis, 20% had compensated metabolic acidosis, 5% showed signs of respiratory alkalosis, 5% had mixed acid-base disturbances, and 5% were indeterminate due to incomplete records. Only 10% of the cases had documented acid-base interpretation and fluid therapy plans, with 5% including a detailed plan that noted a switch to sodium chloride solution based on acid-base results. Conclusion: The study demonstrates that disturbances or alterations in fluid therapyadministration can significantly impact a patient’s recovery rate and cellular repairprocesses. This small-scale investigation highlights a critical deficiency in evidencebased guidelines for fluid therapy selection based on a patient’s acid-base status. The findings emphasize a substantial gap within the veterinary profession regarding the interpretation of acid-base disorders, as clinical records often lacked detailed interpretation of acid-base results or supportive notes outlining the clinician's treatment plan during intravenous fluid therapy.